Welcome to our dedicated page for Ginkgo Bioworks Holdings news (Ticker: DNA), a resource for investors and traders seeking the latest updates and insights on Ginkgo Bioworks Holdings stock.
Ginkgo Bioworks Holdings, Inc. reports developments around cell engineering, autonomous laboratory infrastructure, and contract research services that make biological R&D more programmable. Its updates cover Ginkgo Cloud Lab, Datapoints and Solutions services, Reconfigurable Automation Carts, Catalyst automation software, and AI-enabled workflows for protein engineering, nucleic acid design, cell-free systems, and biological manufacturing.
Company news also includes financial-results presentations, customer and research collaborations, agricultural biotechnology manufacturing work, and capital or governance updates. Following the completed divestiture of its Biosecurity business, recurring coverage centers on Ginkgo's autonomous lab strategy, remote wet-lab access, microbial strain engineering, fermentation processes, and the commercial use of lab-generated biological data.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Voodoo Scientific and Ginkgo Bioworks (NYSE: DNA) have announced a collaboration to develop an enzymatic solution for eliminating the harsh "bite" in distilled alcoholic beverages. Voodoo will leverage Ginkgo's Enzyme Services to optimize an enzyme that can be used in spirits manufacturing, from craft to global-scale production.
The enzymatic solution targets specific compounds responsible for alcohol harshness without affecting other flavor components. It can be added as a processing aid during fermentation, requiring no changes to existing production processes. This innovation aims to enable distillers to produce ultra-premium, smoother spirits and develop new flavor profiles across various spirit types.
Voodoo's solution was recently recognized as a top innovation at the Distilled Spirits Council of the United States' (DISCUS) annual conference. The collaboration combines Voodoo's industry-specific knowledge with Ginkgo's protein discovery and design capabilities.
Summary not available.
Summary not available.
Summary not available.
Summary not available.
Summary not available.